Last updated: Nov 20, 2026, 12:00 AM

Enliven Therapeutics Inc. Exchange (NASDAQ, USD)

ELVN

46.53
-1.18 (-2.42%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
134.93%
3 year return (CAGR)
60.35%
5 year return (CAGR)
-4.31%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
3.49B
Price/Sales
-
Ent value
3.37B
Price/Book
3.90
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-9.23%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open48.58
Daily high48.90
Daily low47.30
Daily Volume694K
All-time high877.92
1y analyst estimate74.42
Beta0.36
EPS (TTM)-1.60
Dividend per share0.00
Ex-div date-
Next earnings date12 Mar 2026

Ready to capitalize on Enliven Therapeutics Inc.'s growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
ELVNS&P500
Current price drop from All-time high-94.70%-11.46%
Highest price drop-98.85%-56.47%
Date of highest drop12 Dec 20239 Mar 2009
Avg drop from high-88.46%-10.64%
Avg time to new high84 days12 days
Max time to new high1617 days1805 days